FdaApplication
ANDA 209025
Identifiers
- fda_app_no: ANDA209025
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2017-12-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 5MG | TABLET;ORAL |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 2.5MG | TABLET;ORAL |
2 products